Skip to main content
logo
Dicot Pharma AB (STO:DICOT)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1796
0.00 (0.00%)
At close: Jul 24, 2026

Dicot Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-73.8-82.4-59.25-45.01-31.72-27.17
Net Income
-72-80.2-57.7-44.16-31.76-27.17
Earnings Per Share
-0.04-0.04-0.05-0.26-0.26-0.52
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
56.269.19113.4247.349.3830.33
Net Cash Growth
-39.44%-39.00%139.58%404.88%-69.08%49.20%
Cash & Investments
56.269.19113.4247.349.3830.33
Net Cash Per Share
0.030.040.080.070.080.58

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-78.45-85.85-58.87-45.23-29.71-25.87
Capital Expenditures
---00-
Free Cash Flow
-78.45-85.85-58.87-45.23-29.71-25.87
Free Cash Flow Growth
------